Follow the Bavarian Nordic A/S stock price and the full directors' dealings record of the company, a listed issuer based in Denmark. Shares trade on the DK market, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Bavarian Nordic A/S has recorded 84 insider filings. Market capitalisation: €16.1bn. The latest transaction was reported on 4 September 2026 (Subscription). The full history is openly available.
84
Insider Decl.
n/a
Thresholds
€1m
8 ops.
Buy Volume
€6m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bavarian Nordic A/S Strong Buy (bullish), based on 4 analysts. Average price target: DKK 276.25.
24Σ signal
Buys €1m€6m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,093 of 29,063 companies
80.5
score / 100
Value
82
Quality
80
FCF yld8.4%
Earn yld8.5%
EV/EBITDA6.4x
ROE12%
Gross mgn49%
Net mgn22%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,642 shares@ DKK 151.550.012% mcap1.8% of flowShareOutside a trading venueISINISIN DK0015998017DK:1210681
25 of 84 declarations
Acerca de Bavarian Nordic A/S
Bavarian Nordic A/S es una empresa biofarmacéutica danesa centrada en el desarrollo de vacunas y tratamientos para enfermedades infecciosas y cáncer. Pone énfasis en la innovación en vacunas terapéuticas y preventivas.